1163: both vedolizumab and anti-tnf therapy are associated with attenuation of serological and neutralizing responses to sars-cov-2 infection in inflammatory bowel disease

GASTROENTEROLOGY(2022)

引用 0|浏览12
暂无评分
关键词
inflammatory bowel disease,vedolizumab,anti-tnf,sars-cov
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要